HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Peer reviews of risk assessments would be required for "major" rules under HR 9.

This article was originally published in The Rose Sheet

Executive Summary

RISK ASSESSMENTS PEER REVIEW WOULD BE REQUIRED UNDER HR 9, Title III of the "Job Creation and Wage Enhancement Act," a part of a broad effort by House Republicans to decentralize and reduce the power of the federal government and increase the accountability of federal officials. Part of the House Republican "Contract With America," the measure was introduced Jan. 4 by Rep. Bill Archer (R-TX). Under Title III, which addresses risk assessment and cost benefit analyses for new regulations, each agency would be required to create peer review panels to consider "any significant risk and cost assessment" prepared in connection with any "major rule."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel